New portfolio company poised to accelerate commercialization

A4i, an innovative digital platform for supporting people with complex behavioural and mental health conditions, been funded by the Ontario Brain Institute (OBI) to support commercialization efforts, with a focus on expanding their presence within Ontario. Growth priorities include expanding existing partnerships with hospitals and forging new strategic alliances to advance access to care for those with severe mental illness.

Dr. Tom Mikkelsen, OBI’s President and Scientific Director, explained the long-term benefits of funding the A4i platform.

“According to the Brain Health in Ontario report, provincial health data tells us that approximately 130,000 Ontarians live with schizophrenia – a number that doesn’t even include other severe mental illnesses," he said. "Given that a new digital platform has been developed to target the recovery processes in psychosis and schizophrenia, as well as in newly in opioid use disorders, OBI is pleased to partner with the founders of A4i in support of their mission to bring an accessible and scalable solution to those impacted by mental health conditions."

Read more about A4i on LinkedIn or via the full announcement.